For relapsed or resistant DLBCL, odronextamab produced positive results.

Published Date: 22 Dec 2023

Experts are unsure of how it would fit in with the currently accepted bispecifics, though.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.

2.

Early PET May Help Tailor Therapy in Hodgkin Lymphoma

3.

An understudied type of breast cancer poses a lurking threat

4.

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

5.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot